177Lu-PSMA-I

Overview of attention for article published in Frontiers in oncology, March 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,533 followers.

New research: 177Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians: Purpose There is increasing evidence for convincing efficacy and safety of 177Lu-labled… https://t.co/

24 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.